Butenafine Hydrochloride Cream
Product Images NDC 73581-210

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Butenafine Hydrochloride (NDC 73581-210). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Yyba Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Butenafine 01)

An anatomical illustration of a foot with red target marks highlighting the spaces between the toes, indicating focal points commonly associated with topical treatment or areas of concern for fungal infections.*

FDA Label Image

Principal Display Panel (30 g Tube Carton)

Butenafine Hydrochloride Cream 1% topical antifungal packaged in a 30 g (1 oz) container. The label emphasizes its prescription strength and use for athlete's foot between the toes, indicating relief for itching, burning, and cracking. The product is distributed by Wellspring and made in Canada, with a reference to comparison against the active ingredient in Lotrimin Ultra. Labeler is YYBA CORP.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.